Skip to main content
Contact
Submit RFP

      The changed economic, social and geopolitical situation, characterised by political tensions and armed conflicts, has ushered in a new, more volatile era for the life sciences and chemical industries. Companies in both sectors are undergoing a process of transformation.

      They are being called upon to become significantly more agile, digital and networked within their respective ecosystems. The change and individualisation of customer needs remain one of the major challenges. However, issues such as digital transformation, stable supply chains and holistic sustainability are also the focus of life sciences and chemical companies.

      Becoming more agile, digital and connected in the ecosystems

      Digitalisation in the life sciences industry primarily affects the areas of digitalisation in research and development and production, patient and doctor interactions, and digital therapies. Collaboration with start-ups and technology companies can make a big difference here. In addition, life sciences companies must improve their ESG performance by continuously expanding their social contribution to even broader and more affordable healthcare, in addition to decarbonisation.

      The German chemical industry continues to face serious challenges, for example in the area of supply chains in Asia and China. However, sharply rising raw material prices, their availability, the stability of energy supplies and increased sustainability requirements are also putting pressure on companies. The development of resilient supply networks, the adaptation of the energy mix and further digitalisation will play a decisive role in the future.

      Our experts will help you to better position your company for the future and support you in your transformation into a more customer-oriented and competitive company.

      Companies in the life sciences industry are required to become much more agile, digital and networked in their respective ecosystems. The development of resilient supply networks, the adaptation of the energy mix and further digitalisation will play a decisive role in the future.

      Christian Klingbeil
      Christian Klingbeil

      Partner, Deal Advisory, Valuation, Head of Life Sciences & Chemicals

      KPMG AG Wirtschaftsprüfungsgesellschaft

      Focus on industry topics

      Generative AI in the life sciences industry

      How GenAI is accelerating research, driving personalised medicine across the board and requiring new corporate structures.
      Download now
      Finger on screen in white room

      Our range of services

      KPMG supports you in mastering these challenges. Our services are customised to meet the needs of our clients. We offer you flexible and well-coordinated teams that comprehensively cover the auditing and advisory needs of your company. In addition, our integration into a global network enables us to quickly identify current trends.

      Our employees are not only specialists in their fields. They also have industry-specific expertise, which we pool in our Chemicals and Pharmaceuticals sector.

      • We support and advise you on topics such as
        • Strategies and concepts for investments in new markets
        • Portfolio optimisation (e.g. carve-out)
        • Acquisition and sale of (parts of) companies in Germany and abroad
        • Transaction consulting (e.g. due diligence)
        • Company valuation (e.g. purchase price allocation)
        • Integration consulting
        • Restructuring
        • Support with initial public offerings (IPO)
        • IT consulting
        • Cyber security
        • Digital transformation
        • Research & development - optimisation and controlling
        • Supply chain optimisation
        • Profitability and cost optimisation
        • Mass data analysis (big data)
        • Tax mapping of changed value creation processes
      • In the Audit and Tax divisions, we can assist you with the following topics, among others:
        • Audit of annual and consolidated financial statements
        • Audit of sustainability information and reports
        • Climate reporting and CO2 balances
        • Auditing of management systems for the environment, energy, occupational safety and quality
        • Support in connection with M&A cases, national and international
        • EUGH case law - application and implementation
        • Transfer pricing planning and subsequent operational implementation and automation (operational transfer pricing) as well as transfer pricing compliance
        • Global mobility services (e.g. international employee deployment)
        • Indirect tax services (e.g. value added tax, customs law)
      Interested in our services? Contact us

      Chemicals 4.0: How the chemical industry is implementing ESG

      The chemical industry is in a decisive phase of transformation. We show you what is important.

      Download now
      Windkraftanlagen und Sonnenblume

      More KPMG Insights

      Newsletter

      The latest news and trends from the life sciences sector - delivered to your mailbox free of charge.

      attach_email

      Stay well informed about transactions in the global chemicals industry
      Register now
      attach_email

      Stay well informed about transactions in the global life sciences industry
      Register now

      Your contacts